Chemical compound lights up treatment-resistant cancers on imaging scans

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

BU professor recognized for excellence in the field of traumatic stress studies

Denise M. Sloan, PhD, professor of psychiatry at Boston University Chobanian & Avedisian School of Medicine and Senior Clinician Investigator, Behavioral Science Division, National Center

October 7, 2024

Opinion | Bullet-Related Injuries: ‘The Problem Is Our Relationship to Lethal Force’

Jeremy Faust is editor-in-chief of MedPage Today, an emergency medicine physician at Brigham and Women’s Hospital in Boston, and a public health researcher. He is

June 22, 2024

Extreme Temps and Particulate Matter in Fatal Heart Attacks; Impact of Thymectomy

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

August 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.